Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) EPS (Basic) (2016 - 2025)

Standard Biotools (LAB) has disclosed EPS (Basic) for 16 consecutive years, with -$0.09 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Basic) fell 50.0% to -$0.09 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.33, a 49.23% increase, with the full-year FY2024 number at -$0.52, up 44.68% from a year prior.
  • EPS (Basic) was -$0.09 for Q3 2025 at Standard Biotools, roughly flat from -$0.09 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.06 in Q3 2024 to a low of -$0.99 in Q1 2022.
  • A 5-year average of -$0.26 and a median of -$0.22 in 2023 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): crashed 296.0% in 2022, then surged 78.79% in 2023.
  • Standard Biotools' EPS (Basic) stood at -$0.12 in 2021, then crashed by 116.67% to -$0.26 in 2022, then increased by 3.85% to -$0.25 in 2023, then soared by 68.0% to -$0.08 in 2024, then dropped by 12.5% to -$0.09 in 2025.
  • Per Business Quant, the three most recent readings for LAB's EPS (Basic) are -$0.09 (Q3 2025), -$0.09 (Q2 2025), and -$0.07 (Q1 2025).